abstract |
New polymorphs and co-crystals of compounds useful in the treatment, prevention or amelioration of cancer are provided. In particular, the present invention relates to 6-{(1R) -1- [8-fluoro-6- (1-methyl-1H-pyrazol-4-yl) [1.2.4] triazolo, which is an inhibitor of c-Met. Polymorphs and co-crystals of [4,3-a] pyridin-3-yl] ethyl} -3- (2-methoxyethoxy) -1,6-naphthyridin-5 (6H) -one are provided. [Selection figure] None |